{"id":4000,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:23:12","modified_gmt":"2026-02-17T10:23:12","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/pl\/andromedic-esho-2014\/","title":{"rendered":"Andromedic ESHO 2014"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/pl\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/pl\/andromedic-esho-2014\/\",\n      \"name\": \"Badania kliniczne z Andromedic HyDeep 600 WM - Kongres ESHO\",\n      \"description\": \"Dane z bada\u0144 klinicznych nad HyDeep 600 WM w leczeniu raka szyjki macicy oraz wieloo\u015brodkowe badania wykonalno\u015bci prezentowane na kongresie ESHO.\",\n      \"inLanguage\": \"pl-PL\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Badanie LACC nad rakiem szyjki macicy\",\n          \"description\": \"Badanie na 8 pacjentkach wykazuj\u0105ce 100% kontroli miejscowej przy u\u017cyciu systemu HyDeep 600 WM i brachyterapii HDR.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Rak szyjki macicy\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Hiszpa\u0144skie badanie kliniczno-kontrolne\",\n          \"description\": \"Zakrojone na szerok\u0105 skal\u0119 badanie wykonalno\u015bci z udzia\u0142em 293 pacjent\u00f3w w 9 lokalizacjach nowotworowych.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Zaawansowany system hipertermii onkologicznej \/ profesjonalne urz\u0105dzenie do miejscowej hipertermii g\u0142\u0119bokiej z modulacj\u0105 RF (13,56 MHz).\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/pl\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Cena na zapytanie\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Najnowocze\u015bniejsza technologia hipertermii g\u0142\u0119bokiej z klinicznie potwierdzonymi protoko\u0142ami.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">Europejskie Towarzystwo Onkologii Hipertermicznej: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Interwencja Andromedic \u2013 dr Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">Podczas konferencji <a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a>, <a href=\"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\"><strong>dr Salvatore Conte<\/strong><\/a> og\u0142osi\u0142 kamie\u0144 milowy dla zespo\u0142u hipertermii Andromedic: udan\u0105 produkcj\u0119 i dostarczenie 25 <a href=\"https:\/\/andromedichyperthermia.com\/pl\/urzadzenie-do-hipertermii-andromedic\/\">urz\u0105dze\u0144 do g\u0142\u0119bokiej hipertermii lokalnej <strong>HyDeep 600WM<\/strong><\/a> w zaledwie 18 miesi\u0119cy, z kolejnymi 40 jednostkami przeznaczonymi na rynek indyjski.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase;\">Prezentowane badania kliniczne: HyDeep 600WM zaawansowana hipertermia onkologiczna<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Radiochemioterapia + hipertermia + brachyterapia HDR w leczeniu LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>CELE:<\/strong> Zbadanie wynik\u00f3w po\u0142\u0105czenia cotygodniowego podawania cisplatyny i g\u0142\u0119bokiej hipertermii lokalnej z IMRT, a nast\u0119pnie brachyterapi\u0105 (BRT) w leczeniu miejscowo zaawansowanego raka szyjki macicy (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MATERIA\u0141Y I METODY:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n<li><strong>Grupa pacjent\u00f3w:<\/strong> 8 pacjentek (3 w stadium IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<li><strong>Protok\u00f3\u0142:<\/strong> 50,4 Gy na w\u0119z\u0142y ch\u0142onne miednicy z SIB na GTV (\u0142\u0105cznie 61,8 Gy) w 28 frakcjach. Dawka BRT: 21 Gy w 3 frakcjach.<\/li>\n<li><strong>Terapia skojarzona:<\/strong> Cotygodniowa cisplatyna 40mg\/m\u00b2 + HT raz w tygodniu.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">WYNIKI I WNIOSKI:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">OSI\u0104GNI\u0118TO 100% KONTROLI MIEJSCOWEJ. Nie zaobserwowano ostrej ani p\u00f3\u017anej toksyczno\u015bci stopnia 3-4 zwi\u0105zanej z leczeniem.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">&#8222;Dodanie g\u0142\u0119bokiej hipertermii lokalnej do radiochemioterapii stanowi obiecuj\u0105c\u0105 now\u0105 strategi\u0119 o doskona\u0142ej tolerancji.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Badanie wykonalno\u015bci (Case-Control) \u2013 g\u0142\u0119boka hipertermia lokalna &#8211; Andaluzja, Hiszpania<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>Wst\u0119p:<\/strong> Pierwsze w Hiszpanii badanie kliniczne \u0142\u0105cz\u0105ce g\u0142\u0119bok\u0105 hipertermi\u0119 lokaln\u0105 ze standardowymi metodami leczenia nowotwor\u00f3w w ramach publicznego systemu opieki zdrowotnej.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Konstrukcja badania:<\/strong> Prospektywne badanie kliniczno-kontrolne. \u0141\u0105cznie 293 pacjent\u00f3w (97 w fazie aktywnej vs 196 w grupie kontrolnej). 9 lokalizacji nowotwor\u00f3w.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Parametry leczenia:<\/strong> 10 sesji (2-3\/tydzie\u0144), czas trwania 1 godzina, moc 150W\u2013400W przy u\u017cyciu <strong>urz\u0105dzenia do modulowanej hipertermii HyDeep 600WM<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">Dane wst\u0119pne (podgrupa 22 pacjent\u00f3w):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li><strong>Glejaki (2c)<\/strong><\/li>\n<li><strong>Nowotwory g\u0142owy i szyi (7c)<\/strong><\/li>\n<li><strong>Przedoperacyjny rak odbytnicy (3c)<\/strong><\/li>\n<li><strong>Rak piersi (3c)<\/strong><\/li>\n<li><strong>P\u0142uca (NSCLC &#8211; 11c)<\/strong><\/li>\n<li><strong>Prostata (4c)<\/strong><\/li>\n<li><strong>Szyjka macicy i przerzuty<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81.2%<\/span><br \/>\n<strong>WYSOKA TOLERANCJA<\/strong><br \/>\n<small>Pacjenci zadowoleni lub bardzo zadowoleni<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66.6%<\/span><br \/>\n<strong>BRAK TOKSYCZNO\u015aCI<\/strong><br \/>\n<small>Nie zg\u0142oszono dzia\u0142a\u0144 niepo\u017c\u0105danych<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>WNIOSKI:<\/strong> G\u0142\u0119boka hipertermia lokalna jest mo\u017cliwa do wdro\u017cenia w rutynowej opiece szpitalnej bez nadzwyczajnych nak\u0142ad\u00f3w. W\u0142a\u015bciwy dob\u00f3r pacjent\u00f3w gwarantuje minimaln\u0105 toksyczno\u015b\u0107 (stopnia 1).<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Pobierz pe\u0142ny protok\u00f3\u0142 badania (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">Plakaty naukowe i dokumentacja ESHO<\/h3>\n<div id='gallery-1' class='gallery galleryid-4000 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/pl\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1337\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1337'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/pl\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1316\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1316'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/pl\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1295\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1295'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Europejskie Towarzystwo Onkologii Hipertermicznej: ESHO 2014 Interwencja Andromedic \u2013 dr Salvatore Conte Podczas konferencji ESHO 2014, dr Salvatore Conte og\u0142osi\u0142 kamie\u0144 milowy dla zespo\u0142u hipertermii Andromedic: udan\u0105 produkcj\u0119 i dostarczenie 25 urz\u0105dze\u0144 do g\u0142\u0119bokiej hipertermii lokalnej HyDeep 600WM w zaledwie 18 miesi\u0119cy, z kolejnymi 40 jednostkami przeznaczonymi na rynek indyjski. Prezentowane badania kliniczne: HyDeep 600WM&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17349,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-4000","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/pages\/4000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/comments?post=4000"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/pages\/4000\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/media\/17349"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/pl\/wp-json\/wp\/v2\/media?parent=4000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}